Advertisement FDA approves ciclopirox topical solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves ciclopirox topical solution

Hi-Tech Pharmacal has announced that the FDA has granted final approval to the company's abbreviated new drug application for ciclopirox topical solution, 8%.

Hi-Tech’s ciclopirox topical solution is the generic equivalent of Dermik Laboratories’ nail fungus treatment penlac topical solution, which had sales of $87 million in 2006 based on IMS sales data.